Gary D. Luker

This paper shows that immunomodulatory nanoparticles reprogram monocytes to resolve pulmonary fibrosis by inducing antifibrotic immune activation and ECM degradation.

This paper introduces a Bayesian framework for optimizing drug dose-response assays to improve information efficiency and reduce trial-and-error in cancer research.

This study shows that substrate stiffness affects CXCR4 and EGFR expression and signaling in TNBC cells, promoting Akt and ERK activation and migration.

This paper introduces TRAP, a light-triggered protease system for controlled secretion from synthetic cells, demonstrating its ability to release fluorescent and luminescent proteins.

The paper uses a cholesterol PET radiotracer to predict immunotherapy response in TNBC mouse models by measuring T cell cholesterol uptake.